The stock of Port Erin Biopharma Investments Ltd (LON:PEBI) is a huge mover today! The stock increased 11.11% or GBX 0.62 on November 16, hitting GBX 6.25. About 30,000 shares traded hands or 48.74% up from the average. Port Erin Biopharma Investments Ltd (LON:PEBI) has risen 30.81% since April 15, 2016 and is uptrending. It has outperformed by 26.13% the S&P500.
The move comes after 8 months positive chart setup for the GBX 1.68 million company. It was reported on Nov, 16 by Barchart.com. We have GBX 8.13 PT which if reached, will make LON:PEBI worth GBX 504,000 more.
More news for Port Erin Biopharma Investments Ltd (LON:PEBI) were recently published by: Prnewswire.com, which released: “Bontan changes its name to Portage Biotech Inc. and jurisdiction to BVI” on July 31, 2013. Reuters.com‘s article titled: “Port Erin Biopharma Investments Ltd announces no dividend” and published on March 31, 2014 is yet another important article.
Port Erin Biopharma Investments Limited invests in the biotechnology and biopharmaceutical sector. The company has a market cap of 1.68 million GBP. The Firm focuses on creating value for shareholders through investing in companies that have the potential to generate revenues through the development of biopharmaceutical drugs. It currently has negative earnings. The Firm invests in equity and equity-related products in both quoted companies, which offer the benefits of liquidity, and in unquoted companies, which offers the additional capital gains upon completion of an Initial Public Offering .
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.